Evidence map›Paper›PMID 15082762›Full record

ArticleMolecular and cellular biology2004

A novel protein with similarities to Rb binding protein 2 compensates for loss of Chk1 function and affects histone modification in fission yeast.

Shakil Ahmed, Carmela Palermo, Shanhong Wan, Nancy C Walworth

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Msc1 links dynamic Swi6/HP1 binding to cell fate determination.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shakil AhmedDepartment of Pharmacology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey and Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA.
Carmela Palermo
Shanhong Wan
Nancy C Walworth
Rutgers, The State University of New Jersey · USJohnson University · US

Funding

Cell Cycle Checkpoint in Response to DNA DamageR01GM053194 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WALWORTH, NANCY C. · 1995 to 2011
$4.4M
NIGMS NIH HHS R01 GM053194NIGMS NIH HHS R01GM53194
6 · The paper itself

Abstract

The conserved protein kinase Chk1 mediates cell cycle progression and consequently the ability of cells to survive when exposed to DNA damaging agents. Cells deficient in Chk1 are hypersensitive to such agents and enter mitosis in the presence of damaged DNA, whereas checkpoint-proficient cells delay mitotic entry to permit time for DNA repair. In a search for proteins that can improve the survival of Chk1-deficient cells exposed to DNA damage, we identified fission yeast Msc1, which is homologous to a mammalian protein that binds to the tumor suppressor Rb (RBP2). Msc1 and RBP2 each possess three PHD fingers, domains commonly found in proteins that influence the structure of chromatin. Msc1 is chromatin associated and coprecipitates a histone deacetylase activity, a property that requires the PHD fingers. Cells lacking Msc1 have a dramatically altered histone acetylation pattern, exhibit a 20-fold increase in global acetylation of histone H3 tails, and are readily killed by trichostatin A, an inhibitor of histone deacetylases. We postulate that Msc1 plays an important role in regulating chromatin structure and that this function modulates the cellular response to DNA damage.

Indexed as

Intracellular Signaling Peptides and ProteinsTumor Suppressor ProteinsAcetylationAmino Acid MotifsCarrier ProteinsCell CycleCell NucleusCheckpoint Kinase 1ChromatinDNA-Binding ProteinsDNA DamageGene DeletionHistone Deacetylase InhibitorsHistone DeacetylasesHistonesHumansCarrier ProteinsCheckpoint Kinase 1CHEK1 protein, humanChk1 protein, S pombeChromatinDNA-Binding ProteinsHistone Deacetylase InhibitorsHistone DeacetylasesHistonesHydroxamic AcidsIntracellular Signaling Peptides and ProteinsKDM5A protein, humanMsc1 protein, S pombeProtein KinasesRetinoblastoma-Binding Protein 2Retinoblastoma ProteinSchizosaccharomyces pombe Proteinstrichostatin ATumor Suppressor Proteins

Identifiers

PMID15082762
PMCPMC387755
OpenAlexW2155219718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.